Cargando…
Mucormycosis—A serious threat in the COVID-19 pandemic?
Autores principales: | Szarpak, Lukasz, Chirico, Francesco, Pruc, Michal, Szarpak, Luiza, Dzieciatkowski, Tomasz, Rafique, Zubaid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139429/ https://www.ncbi.nlm.nih.gov/pubmed/34029629 http://dx.doi.org/10.1016/j.jinf.2021.05.015 |
Ejemplares similares
-
Variant lambda of the severe acute respiratory syndrome coronavirus 2: A serious threat or the beginning of further dangerous mutations
por: Szarpak, Lukasz, et al.
Publicado: (2022) -
Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19
por: Pruc, Michal, et al.
Publicado: (2020) -
Myocarditis: A complication of COVID-19 and long-COVID-19 syndrome as a serious threat in modern cardiology
por: Szarpak, Lukasz, et al.
Publicado: (2022) -
Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
por: Szarpak, Lukasz, et al.
Publicado: (2022) -
Heart inflammation risk after COVID-19 vaccine
por: Szarpak, Lukasz, et al.
Publicado: (2021)